SARAH NICKELLS: Open Payments
NPI 1558312439 · BEAVER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,311 in 74 payments from 15 companies in 2025. Trend: 2023 $1,221 · 2024 $1,657 · 2025 $1,311
Food & beverage: $1,311
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 13 | $256 |
| Amgen Inc. | 10 | $179 |
| ABBVIE INC. | 13 | $167 |
| Lilly USA, LLC | 8 | $164 |
| Novo Nordisk Inc | 8 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $139 |
| PFIZER INC. | 3 | $61 |
| Alkermes, Inc. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| ACADIA Pharmaceuticals Inc | 1 | $30 |
Products named: TRELEGY ELLIPTA, MOUNJARO, JARDIANCE, EVENITY, QULIPTA, UBRELVY, Ozempic, Rybelsus.
Industry payments across PA — which companies pay providers there.
